To compare suicide rates with versus without long-term lithium treatment in major affective disorders.
Fatality rates due to suicide during maintenance lithium treatment were compared with rates after the discontinuation of lithium or in untreated samples. Study-specific rates were estimated for on-and off-lithium groups in each study. The confidence intervals (95% CIs) of these rates were estimated using Poisson-modelling methods for study groups with non-zero suicide rates and exact estimation methods (also Poisson-based) for studies with zero rates.
A study that found no suicides in either treatment group was excluded from the analysis. Eight studies examined the outcomes after lithium discontinuation, and thus have the potential for treatment discontinuation effects. For these studies, the suicide risk ratios were estimated using survival analysis methods.
The mid-point of time-on-lithium and half of the exposure-time without lithium were taken as the best estimates of time to suicide for on-and off-lithium conditions in the other studies. Time-at-risk for non-suicidal patients was assumed to be the entire exposure time during lithium treatment.
The methods of DerSimonian and Laird were used to combine the risk-ratios obtained for all 12 studies providing nonzero suicide rates with or without lithium treatment. The use of fixed-effect or random-effects models to estimate pooled suicide risk ratios depended upon the size of the Q-statistic.
Publication bias was assessed using a funnel-plot.
How were differences between studies investigated?
Heterogeneity was assessed using the Q-statistic. The presence of studies unduly influencing statistical modelling was assessed by omitting one study at a time from the estimation procedure; the outlier status was verified by Q-tests. Sensitivity analyses, substituting other interval percentiles for the exposure mid-point, were performed to assess the impact of using interval mid-points in estimating the time-at-risk for suicidal patients. Bivariate analyses were used to correlate study treatment group-specific suicide rates with study size, year of publication, diagnostic categories, use of blinded versus open study designs, the presence of lithium discontinuation as a potential risk factor, the presence of one or two treatment conditions, and the overall ratings of study quality. These were carried out for all studies, based on Spearman rank correlations and random-effects regression modelling. Random-effects meta-regression methods were used in 12 studies with on-and off-lithium subgroups.
Results of the review
Twenty-two studies with a total of 5,647 participants were included. Only 3 studies were blinded randomised controlled trials.
The aggregate suicide rate, based on a weighted random-effects model, was 0.159%/year (95% CI: 0.133, 0.204) during lithium treatment and 0.875%/year (95% CI: 0.630, 1.119) off-lithium. This indicated an overall 5.50-fold lower crude suicide risk associated with lithium treatment.
Twelve studies, which included patients with and without lithium treatment and non-zero suicide rates without treatment, yielded overall suicide rates of 1.02%/year (95% CI: 0.80, 1.29) without treatment versus 0.15%/year (95% CI: 0.10, 0.23) with lithium treatment, a significant crude difference of nearly 7-fold (P<0.001). However, there was significant heterogeneity (Q=23.4, P=0.016). Therefore, the random-effects model was used to estimate the log risk ratio for the on-versus off-lithium contrast. The pooled log rate ratio was 2.18 (95% CI: 1.42, 2.95), indicating a risk ratio of 8.85 (95% CI: 4.14, 19.1), which was highly significantly different from the null risk ratio of 1.0 (P<0.0001). The removal of any single study did not significantly affect the pooled risk ratio estimate.
Bivariate analyses of suicide rates found no significant relationships between suicide rates, either with or without lithium treatment, and the number of participants in the study, study quality score, blind study design, discontinuation of lithium, diagnoses, exposure time or publication year. These conclusions were sustained in multivariate logistic regression analyses.
The off-lithium suicide rates did not differ significantly between the 8 studies that involved treatment discontinuation (1.009%/year, 95% CI: 0.754, 1.323) and the 5 studies that did not (1.052%/year, 95% CI: 0.660, 1.593) (P=0.91). This comparison, and the higher suicide rate in studies that involved observations only in lithium-treated patients, suggested that it was unlikely that lithium-treated patients had a lower suicide risk independent of treatment, or that treatment
